When miR-214-3p from microvesicles enters CD4+T cells and down-regulates PTEN, it can inhibit tumor through antagonizing phosphorylase activity, such as tyrosine kinase (Myers et al., 1998; Yang et al., 2008). This evidence concerns the gene PTEN and neoplasm.